>Go!

Executive Leadership

Driving continued growth, success and achievement

Chairman, President and CEO, Allergan Image

Chairman, President and CEO, Allergan

Brenton L. Saunders

Brent Saunders is Chairman, President and Chief Executive Officer of Allergan plc. Mr. Saunders has served as a Director, CEO and President since July 2014.

  • He was elected Chairman in 2016. Previously, he served as Chief Executive Officer and President of Forest Laboratories and as a Director of Forest since 2011. Mr. Saunders has significant healthcare industry expertise and a proven track-record leading business transformations and integrations. Prior to Forest, Mr. Saunders was Chief Executive Officer of Bausch + Lomb, a leading global eye health company, serving in this capacity from March 2010 until August 2013. Mr. Saunders also held several leadership positions at Schering-Plough, including the position of President of Global Consumer Health Care, and was named head of integration for the company’s merger with Merck & Co. and for Schering-Plough’s acquisition of Organon BioSciences. Before joining Schering-Plough, Mr. Saunders was a partner and head of Compliance Business Advisory at PricewaterhouseCoopers LLP. Prior to that, he was Chief Risk Officer at Coventry Health Care and Senior Vice President, Compliance, Legal and Regulatory at Home Care Corporation of America. Mr. Saunders began his career as Chief Compliance Officer for the Thomas Jefferson University Health System. Mr. Saunders serves on the Board of Directors of Cisco Systems and RWJBarnabas Health, and is a member of the Business Council and PhRMA. He is also the former Chairman of the New York chapter of the American Heart Association. Mr. Saunders earned his MBA from Temple University School of Business, his J.D. from Temple University School of Law and his bachelor’s degree from the University of Pittsburgh.

EVP, Chief Operating Officer, Allergan Image

EVP, Chief Operating Officer, Allergan

Robert A. Stewart

Robert A. Stewart is the Chief Operating Officer, and has served in this role since May 2016.

  • Prior to his current appointment, Mr. Stewart served as President, Generics and Global Operations from March 2015 to May 2016; Chief Operating Officer from July 2014 to March 2015; and President, Global Operations, from August 2010 to July 2014. He joined the company (then Watson) in November 2009 as Senior Vice President, Global Operations. Mr. Stewart has 20 years of experience in global biopharmaceutical leadership, with expertise in all aspects of quality, manufacturing and supply chain management.  Before joining Watson, Mr. Stewart held various positions with Abbott Laboratories, Inc. from 2001 until 2009 where he most recently served as Divisional Vice President, Global Supply Chain, Quality Assurance and prior to this position served as Divisional Vice President for U.S./Puerto Rico and Latin America Plant Operations. Preceding his time at Abbott Laboratories, Inc., he worked for Knoll Pharmaceutical Company from 1995 to 2001 and Hoffman La-Roche Inc. Mr. Stewart has been a North American Manufacturing board member since September 2016. He earned his Bachelor's degree in Business Management and Finance from Fairleigh Dickinson University.

EVP & Chief Commercial Officer Image

EVP & Chief Commercial Officer

William Meury

Bill Meury is the Chief Commercial Officer, and has served in this role since May 2016.

  • Mr. Meury previously served as President, Branded Pharma from March 2015 to May 2016. He joined the Company in July 2014 as Executive Vice President, Commercial, North American Brands. He has significant experience in launching and commercializing healthcare products. Prior to joining Allergan, Mr. Meury served as Executive Vice President, Sales and Marketing at Forest Laboratories, Inc. He joined Forest in 1993 and held multiple roles of increasing responsibility in Marketing, New Products, Business Development, and Sales. Before joining Forest, Mr. Meury worked in public accounting for Reznick Fedder & Silverman and in financial reporting for MCI Communications. Mr. Meury is currently on the Board of Directors of several organizations, including The Jed Foundation, International Council of Ophthalmology Foundation, and The Allergan Foundation. Mr. Meury earned his bachelor’s degree in Economics from the University of Maryland.

EVP & Chief Financial Officer Image

EVP & Chief Financial Officer

Maria Teresa Hilado

Tessa Hilado is the Chief Financial Officer, and has served in this role since December 2014.

  • Ms. Hilado has 30 years of global finance experience. Prior to joining the company, Ms. Hilado served as Senior Vice President, Finance and Treasurer of PepsiCo, Inc. from 2009 to 2014. Before joining PepsiCo, she served as Vice President and Treasurer for Schering-Plough Corporation from 2008 to 2009. Before joining Schering-Plough, Ms. Hilado spent more than 17 years with General Motors Corporation in leadership roles of increasing responsibility, most notably Assistant Treasurer from 2006 to 2008 and CFO, GMAC Commercial Finance LLC from 2001 to 2005. She began her career with Far East Bank and Trust Company, Manila, Philippines. Ms. Hilado currently sits on the Board of Directors at H.B. Fuller, Co. She earned her bachelor’s degree in Management Engineering from Ateneo de Manila University in the Philippines, and an MBA from the University of Virginia’s Darden School of Business Administration.

EVP & Chief Legal Officer and Corporate Secretary Image

EVP & Chief Legal Officer and Corporate Secretary

A. Robert D. Bailey

Bob Bailey is the Chief Legal Officer and Corporate Secretary, and has served in this role since July 2014.

  • Previously, Mr. Bailey served as Senior Vice President, Chief Legal Officer, General Counsel and Corporate Secretary of Forest Laboratories, Inc. Mr. Bailey previously served from 2007 to 2013 as Executive Vice President, Law, Policy and Communications at Bausch + Lomb, and was with the company for more than 16 years. Before joining Bausch + Lomb in 1994, Mr. Bailey was an attorney at Nixon Peabody (formerly Nixon Hargrave Devans & Doyle). Mr. Bailey is a member of the US Chamber Litigation Board of Directors. He earned his law degree from the University of Minnesota and his undergraduate degree from St. Olaf College in Northfield, Minnesota.

EVP & Chief Human Resources Officer Image

EVP & Chief Human Resources Officer

Karen L. Ling, Esq.

Karen Ling is the Chief Human Resources Officer, and has served in this role since July 2014.

  • She previously served as Senior Vice President and Chief Human Resources Officer for Forest Laboratories, Inc. from January to July 2014. Prior to joining Forest, Ms. Ling served as Senior Vice President, Human Resources at Merck & Co., for the company’s Global Human Health and Consumer Care businesses worldwide beginning in November 2011. Previously, she served as Vice President, Compensation and Benefits at Merck and Group Vice President, Global Compensation & Benefits at Schering-Plough (which was acquired by Merck). Prior to joining Schering-Plough in 2008, Ms. Ling spent 14 years at Wyeth Pharmaceuticals in various positions of responsibility in human resources and in Wyeth’s Labor and Employment Department. Before joining Wyeth, Ms. Ling was an attorney at Goldstein and Manello, P.C. in Boston. Ms. Ling is currently a member of the Board of Directors of the Glaucoma Foundation, Inc., a non-for-profit organization. She earned J.D. from Boston University School of Law and a B.A. from Yale University.

EVP & Chief R&D Officer Image

EVP & Chief R&D Officer

C. David Nicholson, PhD

David Nicholson is the Chief R&D Officer, and has served in this role since March 2015.

  • Dr. Nicholson joined the company (then Actavis) as Senior Vice President, Global Brands R&D in August 2014. He has been in research and development in the pharmaceutical industry since 1978. Previously, he served as Chief Technology Officer and EVP, R&D for Bayer CropScience from March 2012 to August 2014; Senior Vice President of Licensing and Knowledge Management at Merck from 2009 to December 2011; and Senior Vice President, responsible for Global Project Management and Drug Safety at Schering-Plough from 2007 to 2009. From 1988 to 2007, Dr. Nicholson held various leadership positions at Organon, where he most recently served as Executive Vice President, R&D and was a member of the company’s Executive Management Committee. Dr. Nicholson earned his B.Sc. from the University of Manchester and his Ph.D. from the University of Wales.

EVP & Chief Communications Officer Image

EVP & Chief Communications Officer

Alex Kelly

Alex Kelly is the EVP, Corporate Affairs and Chief Communications Officer, and has served in this role since April 20, 2015.

  • Previously, Mr. Kelly served as Senior Vice President, Chief Integration Officer since July 2014. In this role, he led the integration of Forest Laboratories following its acquisition by Actavis. He also co-led the integration of Allergan. Prior to joining Actavis, Mr. Kelly was Senior Vice President, Chief Communications Officer, Public Affairs and Investor Relations at Forest Laboratories. In that role, he led Forest’s corporate communications and investor relations programs. While at Forest, Mr. Kelly led the integration of Aptalis Pharma following its acquisition in January 2014. Prior to Forest, Mr. Kelly served as Vice President, Investor Relations at Bausch + Lomb. Mr. Kelly was Senior Vice President, Investor Relations at Merck & Co., Inc. following the combination with Schering-Plough where he led the Global Communications and Investor Relations team. He previously worked for Novartis as Executive Director, Investor Relations, after spending 14 years at Pharmacia, including ten years in pharmaceutical sales and sales management and four years in investor relations. Mr. Kelly currently serves on multiple Boards and Committees, including the California Biomedical Innovation Alliance, The Allergan Foundation, and the HealthCare Institute of New Jersey. He earned his Bachelor of Science in Pharmacy from Purdue University, where he graduated Cum Laude.

Contact Allergan
U.S. ADMINISTRATIVE HEADQUARTERS:
Morris Corporate Center III
400 interpace parkway
Parsippany, NJ 07054
+1 (862) 261-7000